HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Gillette Mach3 Turbo Revs Up Q2 Blade And Razor Sales

This article was originally published in The Rose Sheet

Executive Summary

Gillette blade and razor sales jumped 10% to $884 mil. in the second quarter led by the Mach3 Turbo shaving system, VP-Investor Relations Chris Jakubik said during the company's second quarter financial report July 23

You may also be interested in...



OTC Vaniqa Could Surface By Early 2005

Women First HealthCare may explore Rx-to-OTC switch opportunities forVaniqa facial hair growth retardation cream as early as 2004, the firm stated

Gillette Power Stripe Technology Extended To Soft & Dri, Right Guard

Gillette is continuing to expand its antiperspirant/ deodorant brands with line extensions featuring its new odor-control technology, the Boston company said

Gillette Mach 3 Turbo Offers Innovation At Premium Price, Toiletries Tie In

Gillette will unveil its first joint marketing campaign featuring the new Mach 3 Turbo razor and the reformulated and repackaged Gillette Series men's grooming line, the Boston firm announced during a press event Oct. 30

Latest Headlines
See All
UsernamePublicRestriction

Register

RS010483

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel